Article
Angiotensin-I converting enzyme genotype-dependent benefit from hormone replacement therapy in isometric muscle strength and bone mineral density.
The Journal of clinical endocrinology and metabolism - 1 May 2001
Woods D, Onambele G, Woledge R, Skelton D, Bruce S, Humphries S E, Montgomery H
Abstract excerpt
Low bone mineral density (BMD) and muscle weakness are major risk factors for postmenopausal osteoporotic fracture. Hormone replacement therapy (HRT) reverses the menopausal decline in maximum voluntary force of the adductor pollicis and reduces serum angiotensin-I converting enzyme (ACE) levels....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
